High Dose Chemotherapy and Autologous Transplant for Breast Cancer

To determine survival outcomes for patients with chemosensitive brest cancer after treatment with high dose chemotherapy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Graft vs Host Disease Immune System Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Stanford University Cancer Center

Stanford, California, 94305, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Stage II, III or IV breast cancer
chemosensitive
adequate organ function

Exclusion criteria

prior transplant,
life threatening disease
brain metastases

Treatment and study plan

high dose chemo and auto hematopoietic cell transplant

Procedure

Primary outcomes

Survival

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Registry information

Official study title

High Dose Chemotherapy and Peripheral Blood Progenitor Cell Rescue for Patients With Breast Cancer

Important dates

Primary completion: 2008
Study completion: 2008
First posted: Sep 16, 2005
Registry last updated: Jun 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed